Meeting of the Advisory Committee; Meeting, 32976 [2021-13174]
Download as PDF
<![CDATA[
32976
Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices
comments received will be provided to
the Council.
Public Disclosure of Comments:
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Detailed Council meeting minutes
will be maintained in the Green River
District Office and will be available for
public inspection and reproduction
during regular business hours within 90
days following each meeting. Minutes
will also be posted to the Council web
page.
Authority: 43 CFR 1784.4–2.
Gregory Sheehan,
State Director.
[FR Doc. 2021–13112 Filed 6–22–21; 8:45 am]
BILLING CODE 4310–DQ–P
JOINT BOARD FOR THE
ENROLLMENT OF ACTUARIES
Meeting of the Advisory Committee;
Meeting
Joint Board for the Enrollment
of Actuaries.
ACTION: Notice of federal advisory
committee meeting.
AGENCY:
The Joint Board for the
Enrollment of Actuaries gives notice of
a teleconference meeting of the
Advisory Committee on Actuarial
Examinations (a portion of which will
be open to the public) on July 8 and 9,
2021.
DATES: Thursday, July 8, 2021, from 9:00
a.m. to 5:00 p.m. (EDT), and Friday, July
9, 2021, from 8:30 a.m. to 5:00 p.m.
(EDT).
ADDRESSES: The meeting will be held by
teleconference.
FOR FURTHER INFORMATION CONTACT: Ms.
Elizabeth Van Osten, Designated Federal
Officer, Advisory Committee on
Actuarial Examinations, at (202) 317–
3648 or Elizabeth.j.vanosten@irs.gov.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that the Advisory
Committee on Actuarial Examinations
will meet by teleconference on
Thursday, July 8, 2021, from 9:00 a.m.
to 5:00 p.m. (EDT), and Friday, July 9,
2021, from 8:30 a.m. to 5:00 p.m. (EDT).
The purpose of the meeting is to
discuss topics and questions that may
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:13 Jun 22, 2021
Jkt 253001
be recommended for inclusion on future
Joint Board examinations in actuarial
mathematics and methodology referred
to in 29 U.S.C. 1242(a)(1)(B) and to
review the May 2021 Pension (EA–2L)
and Basic (EA–1) Examinations in order
to make recommendations relative
thereto, including the minimum
acceptable pass scores. Topics for
inclusion on the syllabus for the Joint
Board’s examination program for the
November 2021 Pension (EA–2F)
Examination will be discussed.
A determination has been made as
required by section 10(d) of the Federal
Advisory Committee Act, 5 U.S.C. App.,
that the portions of the meeting dealing
with the discussion of questions that
may appear on the Joint Board’s
examinations and the review of the May
2021 EA–2L and EA–1 Examinations
fall within the exceptions to the open
meeting requirement set forth in 5
U.S.C. 552b(c)(9)(B), and that the public
interest requires that such portions be
closed to public participation.
The portion of the meeting dealing
with the discussion of the other topics
will commence at 1:00 p.m. (EDT) on
July 8, 2021, and will continue for as
long as necessary to complete the
discussion, but not beyond 3:00 p.m.
(EDT). Time permitting, after the close
of this discussion by Committee
members, interested persons may make
statements germane to this subject.
Persons wishing to make oral statements
should contact the Designated Federal
Officer at NHQJBEA@IRS.GOV and
include the written text or outline of
comments they propose to make orally.
Such comments will be limited to 10
minutes in length. Persons who wish to
attend the public session should contact
the Designated Federal Officer at
NHQJBEA@IRS.GOV to obtain
teleconference access instructions.
Notifications of intent to make an oral
statement or to attend the meeting must
be sent electronically to the Designated
Federal Officer by no later than July 1,
2021. In addition, any interested person
may file a written statement for
consideration by the Joint Board and the
Advisory Committee by sending it to
NQJBEA@IRS.GOV.
DEPARTMENT OF JUSTICE
Dated: June 17, 2021.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the
Enrollment of Actuaries.
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. The company plans to
manufacture the above-listed controlled
substances as clinical trial and starting
materials to make compounds for
distribution to its customers. No other
[FR Doc. 2021–13174 Filed 6–22–21; 8:45 am]
BILLING CODE 4830–01–P
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
Drug Enforcement Administration
[Docket No. DEA–856]
Bulk Manufacturer of Controlled
Substances Application: Purisys, LLC.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Purisys, LLC. has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 23, 2021. Such persons
may also file a written request for a
hearing on the application on or before
August 23, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on March, 12, 2021,
Purisys, LLC., 1550 Olympic Drive,
Athens, Georgia 30601–1602, applied to
be registered as a bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
3,4Methylenedioxyamphetamine.
3,4Methylenedioxymethamphetamine.
3,4-Methylenedioxy-Nethylamphetamine.
Psilocybin ........................
Psilocyn ...........................
E:\FR\FM\23JNN1.SGM
23JNN1
Drug
code
Schedule
7400
I
7404
I
7405
I
7437
7438
I
I
]]>Agencies
[Federal Register Volume 86, Number 118 (Wednesday, June 23, 2021)]
[Notices]
[Page 32976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13174]
=======================================================================
-----------------------------------------------------------------------
JOINT BOARD FOR THE ENROLLMENT OF ACTUARIES
Meeting of the Advisory Committee; Meeting
AGENCY: Joint Board for the Enrollment of Actuaries.
ACTION: Notice of federal advisory committee meeting.
-----------------------------------------------------------------------
SUMMARY: The Joint Board for the Enrollment of Actuaries gives notice
of a teleconference meeting of the Advisory Committee on Actuarial
Examinations (a portion of which will be open to the public) on July 8
and 9, 2021.
DATES: Thursday, July 8, 2021, from 9:00 a.m. to 5:00 p.m. (EDT), and
Friday, July 9, 2021, from 8:30 a.m. to 5:00 p.m. (EDT).
ADDRESSES: The meeting will be held by teleconference.
FOR FURTHER INFORMATION CONTACT: Ms. Elizabeth Van Osten, Designated
Federal Officer, Advisory Committee on Actuarial Examinations, at (202)
317-3648 or [email protected].
SUPPLEMENTARY INFORMATION: Notice is hereby given that the Advisory
Committee on Actuarial Examinations will meet by teleconference on
Thursday, July 8, 2021, from 9:00 a.m. to 5:00 p.m. (EDT), and Friday,
July 9, 2021, from 8:30 a.m. to 5:00 p.m. (EDT).
The purpose of the meeting is to discuss topics and questions that
may be recommended for inclusion on future Joint Board examinations in
actuarial mathematics and methodology referred to in 29 U.S.C.
1242(a)(1)(B) and to review the May 2021 Pension (EA-2L) and Basic (EA-
1) Examinations in order to make recommendations relative thereto,
including the minimum acceptable pass scores. Topics for inclusion on
the syllabus for the Joint Board's examination program for the November
2021 Pension (EA-2F) Examination will be discussed.
A determination has been made as required by section 10(d) of the
Federal Advisory Committee Act, 5 U.S.C. App., that the portions of the
meeting dealing with the discussion of questions that may appear on the
Joint Board's examinations and the review of the May 2021 EA-2L and EA-
1 Examinations fall within the exceptions to the open meeting
requirement set forth in 5 U.S.C. 552b(c)(9)(B), and that the public
interest requires that such portions be closed to public participation.
The portion of the meeting dealing with the discussion of the other
topics will commence at 1:00 p.m. (EDT) on July 8, 2021, and will
continue for as long as necessary to complete the discussion, but not
beyond 3:00 p.m. (EDT). Time permitting, after the close of this
discussion by Committee members, interested persons may make statements
germane to this subject. Persons wishing to make oral statements should
contact the Designated Federal Officer at [email protected] and include
the written text or outline of comments they propose to make orally.
Such comments will be limited to 10 minutes in length. Persons who wish
to attend the public session should contact the Designated Federal
Officer at [email protected] to obtain teleconference access
instructions. Notifications of intent to make an oral statement or to
attend the meeting must be sent electronically to the Designated
Federal Officer by no later than July 1, 2021. In addition, any
interested person may file a written statement for consideration by the
Joint Board and the Advisory Committee by sending it to [email protected].
Dated: June 17, 2021.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the Enrollment of Actuaries.
[FR Doc. 2021-13174 Filed 6-22-21; 8:45 am]
BILLING CODE 4830-01-P
